Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00289419Phase 4Completed
Phase 4, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection, ketorolac and epinephrine in postoperative pain (2 arms), sponsored by Aarhus University. Primary endpoint: Consumption of analgesics at 96 hours. Started Feb 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00289419.